BSX vs PG · P/E 20, rev $16.75B vs P/E 25, rev $84.28B
Boston Scientific Corp (BSX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the BSX and PG stock pages for the full models.
Not investment advice.